Coronavirus: The Latest

It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.

Read more on Christmas rules: https://bit.ly/361oNwP |

Read more on travel quarantine changes: https://bit.ly/371PVLG |

'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |

For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.

Read more on the Oxford vaccine: https://bit.ly/2UVfPet |

Read more on Brexit talks: https://bit.ly/36V8f8Y |

Read more on the new quarantine-free list: https://bit.ly/3lMs88H |

For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight against Covid-19. Top of the list? Tackling misinformation.

Track cases in your area: https://bit.ly/2Yohewr |

Read more about the MS drug trial: https://bit.ly/3kB3nuM |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the Pfizer vaccine breakthrough, immunologist Dr Al Edwards tells Theodora Louloudis why the hard work isn't over even once a vaccine is approved, why talk of effective immunisation before Christmas is premature and how this particular vaccine could be particularly difficult to distribute.

Read more about the rise in deaths in England and Wales: https://bit.ly/2GLAwWw |

Read more about unemployment rates: https://bit.ly/3llycof |

Read more about Welsh exams: https://bit.ly/36oNeDo |

Read Sarah Newey 'We should be concerned about the 'mink virus', but not for the reasons you think': https://bit.ly/3lu966w |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As Liverpool becomes England’s first city to be offered mass coronavirus testing, The Telegraph’s Health Editor Laura Donnelly tells Theodora Louloudis why the trial could offer a glimpse into the UK’s future, and why its success hinges on public co-operation.

Read more the UK's R-rate: https://bit.ly/35YCHyB |

Read more about Paris' coronavirus infection rates: https://bit.ly/2HXCEe4 |

Read Ambrose Evans-Pritchard' 'Boris has my full support on lockdown 2.0 - even though I think he’s wrong': https://bit.ly/34T24Tl |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With just eight weeks to go until the big day, Yolanthe Fawehinmi joins Theodora Louloudis to discuss the likelihood of households being allowed to mix nationwide over the festive season.

Read more about England's coronavirus infection rates: https://bit.ly/31TdwMJ|

Read more about the leaked sage documents: https://bit.ly/34GV4ZE|

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Millions more Britons will soon be living under tighter coronavirus restrictions, but Sadiq Khan and Sir Keir Starmer are among the Labour MPs calling for even harsher measures. They want to see a two-week national ’circuit breaker’ lockdown, but would this diminish the problem, or simply delay it? The Telegraph’s Global Health Security Correspondent Sarah Newey tells Theodora Louloudis why the move isn't a silver bullet.

Read Sarah's report from Manaus: www.bit.ly/3diYUe9 |

Read more about Wales' crackdown on English visitors: https://bit.ly/3nT22lN |

Read more about Germany's rise in cases: https://bit.ly/3nUEqNx |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After Boris Johnson announces a new three-tier system of increasingly tough restrictions to determine England’s local lockdowns, University of London virologist Dr Elisabetta Gropelli joins Theodora Louloudis to discuss whether a focus on social interaction is enough to avoid the death rates seen over the country’s first wave.

Find out what tier your area is in: https://bit.ly/2SNBOTo|

Read more about missed cancer screenings: https://bit.ly/371Y8AX|

Read more about China’s mass testing: https://bit.ly/33OpDfj |

Read Sarah Newey’s piece on Manaus in Brazil: https://bit.ly/3diYUe9 |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After Donald Trump and his wife, Melania test positive for coronavirus, Oxford University Professor of US Politics, Adam Smith joins Theodora Louloudis to discuss how this will affect his campaign, and why - if everything goes really wrong - it could lead to a Democratic president before the votes are even counted.

Read more about SNP MP Margaret Ferrier: https://bit.ly/3ilI4vT |

Read more about England's new quarantine rules: https://bit.ly/3cTBWK5 |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As case numbers rise, restrictions rise too. In the wake of England’s new lockdown measures, The Telegraph’s Associate Editor, Camilla Tominey tells Theodora Louloudis whether these are merely the beginning, why Boris Johnson’s own experience of the virus is colouring his response and why she still views the PM as a libertarian leader.

Read the new rules in full: https://bit.ly/2HolciE |

Read Camilla Tominey’s latest analysis: https://bit.ly/35ZrgZk |

Read more about the US death toll: https://bit.ly/2Eo9149 |

Read more about job cuts: https://bit.ly/3iY9R6M |

Read more about French schools: https://bit.ly/363BDLH |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: [email protected] |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.